Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Complete Guide to the Diagnostic Market 2007-2012

Published by: Informa Healthcare

Published: May. 1, 2007 - 250 Pages


Table of Contents


CHAPTER 1 INTRODUCTION
1.1 Technology trends in clinical diagnostics
1.1.1 Molecular diagnostics
1.1.2 Point-of-care testing
1.1.3 Informatics
1.1.4 Microarrays and lab-on-a-chip devices
1.1.5 Laboratory automation
1.2 Drivers and limiters of the IVD market
1.3 Major trends in the IVD market
1.3.1 Targeted therapeutics and diagnostics
1.3.2 Workstation consolidation
1.3.3 Supplier consolidation
1.3.4 Segments of opportunity and risk in the IVD market
CHAPTER 2 INDUSTRY OVERVIEW
2.1 Clinical chemistry segment
2.1.1 Trends in serum/plasma chemistry testing
2.1.2 Critical care testing
2.1.3 Urinalysis testing
2.1.4 Whole blood glucose testing
2.2 Immunodiagnostics market and sub-segments
2.3 Microbiology segment
2.4 Haematology, flow cytometry and cell imaging segments
2.5 Molecular diagnostics segment
2.6 Other IVD market segments
2.6.1 Coagulation testing
2.6.2 Cytology and histology
2.6.3 Other sub-segments
2.7 Regulatory environment
2.8 The EU IVD Directive
2.9 US regulatory requirements
2.10 Regulatory requirements in Japan
2.11 Regulatory requirements in other regions
2.11.1 China
2.11.2 India
2.11.3 Other Asian countries
2.11.4 South Africa
2.11.5 Canada
2.11.6 Australia
2.11.7 Latin America
2.12 Status of harmonisation of regulations between countries
CHAPTER 3 TECHNOLOGY DEVELOPMENTS
3.1 POC testing technology
3.1.1 Impact of device miniaturization
3.1.2 Less invasive and non-invasive testing technologies
3.2 Wireless technologies and POC testing
3.3 Molecular diagnostics technologies
3.3.1 Microarrays in molecular diagnostics
3.3.2 Automation of molecular testing
3.3.3 Advances in genotyping, haplotyping and sequencing technology
3.4 Pharmacogenetic testing
3.5 Advances in informatics technology
3.6 Proteomics technology
CHAPTER 4 MARKET OVERVIEW
4.1 Overview of sales by product segment
4.2 Overview of sales by country
4.3 Analysis of market by application segment
4.4 Role of IVDs in healthcare
4.5 Sites for IVD testing
4.6 Major trends in the IVD market
4.7 Characteristics of the IVD market by region
4.7.1 US market
4.7.2 Japanese market
4.7.3 German market
4.7.4 Italian market
4.7.5 French market
4.7.6 UK market
4.7.7 Spanish market
4.7.8 Chinese market
4.7.9 Indian market
4.8 Future impact of molecular diagnostics, pharmacogenetics and proteomics
4.9 Segments of the IVD products market
CHAPTER 5 PRODUCT SEGMENTS
5.1 Clinical chemistry products
5.1.1 Integrated testing platforms
5.1.2 High-throughput chemistry systems
5.1.3 Mid-range chemistry systems
5.1.4 Low-throughput/alternate site chemistry systems
5.1.5 Urinalysis products
5.1.6 Critical care testing products
5.1.7 Market segmentation for clinical chemistry products
5.2 Immunodiagnostic products
5.2.1 General purpose immunodiagnostic systems
5.2.2 Specialty immunodiagnostic systems
5.2.3 Immunoassay-based blood screening systems
5.2.4 Market segmentation for immunodiagnostic products
5.3 Haematology/cellular analysis and coagulation testing products
5.3.1 Conventional haematology and integrated haematology/flow cytometry systems
5.3.2 Dedicated flow cytometry systems
5.3.3 Flow cytometry reagents
5.3.4 Coagulation testing products
5.3.5 Market segmentation for haematology and coagulation testing products
5.4 Cancer diagnostic products
5.4.1 Tumour marker immunoassays
5.4.2 Occult blood test kits
5.4.3 Immunohistochemistry test kits
5.4.4 PAP smear screening systems and computerised image analysers
5.4.5 Oncogene test kits
5.4.6 Detection of circulating tumour cells
5.4.7 Cancer diagnostics market segmentation
5.5 Molecular diagnostic products
5.5.1 Infectious disease testing products
5.5.2 Blood screening (NAT) products
5.5.3 Genetic testing products
5.5.4 Pharmacogenetic testing products
5.5.5 Viral load/viral genotyping products
5.5.6 Molecular diagnostics market segmentation
5.5.7 POC testing products
5.5.8 Bedside critical care testing products
5.5.9 Alternate site coagulation/platelet function monitoring products
5.5.10 Drugs of abuse screening kits
5.5.11 Professional-use whole blood chemistry testing systems
5.5.12 POC cardiac marker testing products
5.5.13 Rapid infectious disease test kits
5.5.14 Other POC products
5.5.15 POC testing market segmentation
5.6 Home and self-testing products
5.6.1 Whole blood and minimally invasive glucose testing products
5.6.2 Home tests for monitoring of glycated haemoglobin
5.6.3 Coagulation self-testing products
5.6.4 Home pregnancy and fertility products
5.6.5 Home cholesterol testing products
5.6.6 Home drugs of abuse test kits
5.6.7 Home and self-testing market segmentation
5.7 Other IVD products
CHAPTER 6 MARKET ANALYSIS BY END USER
6.1 Traditional laboratory-based testing
6.2 Testing in other sites
6.3 Testing in the US
6.4 Testing in Europe
6.5 Testing in Japan
6.6 Testing in China
6.7 Testing in India
6.8 Testing in the rest of world region
6.9 Future trends
CHAPTER 7 MARKET ANALYSIS BY COUNTRY
7.1 US market
7.1.1 Clinical chemistry market
7.1.2 Critical care testing market
7.1.3 Urinalysis market
7.1.4 Blood glucose market
7.1.5 Immunodiagnostics market
7.1.6 Haematology/flow cytometry market
7.1.7 Microbiology market
7.1.8 Coagulation/platelet function testing market
7.1.9 Molecular diagnostics market
7.1.10 Other product market segments
7.2 Japanese market
7.2.1 Clinical chemistry market
7.2.2 Critical care testing market
7.2.3 Urinalysis market
7.2.4 Blood glucose market
7.2.5 Immunodiagnostics market
7.2.6 Haematology/flow cytometry market
7.2.7 Microbiology market
7.2.8 Coagulation/platelet function testing market
7.2.9 Molecular diagnostics market
7.2.10 Other product market segments
7.3 German market
7.3.1 Clinical chemistry market
7.3.2 Critical care testing market
7.3.3 Urinalysis market
7.3.4 Immunodiagnostics market
7.3.5 Haematology/flow cytometry market
7.3.6 Microbiology market
7.3.7 Coagulation/platelet function testing market
7.3.8 Molecular diagnostics market
7.3.9 Other product market segments
7.4 French market
7.4.1 Clinical chemistry market
7.4.2 Critical care testing market
7.4.3 Urinalysis market
7.4.4 Blood glucose market
7.4.5 Immunodiagnostics market
7.4.6 Haematology/flow cytometry market
7.4.7 Microbiology market
7.4.8 Coagulation/platelet function testing market
7.4.9 Other product market segments
7.5 Italian market
7.5.1 Clinical chemistry market
7.5.2 Critical care testing market
7.5.3 Urinalysis market
7.5.4 Blood glucose market
7.5.5 Immunodiagnostics market
7.5.6 Haematology/flow cytometry market
7.5.7 Microbiology market
7.5.8 Coagulation/platelet function testing market
7.5.9 Molecular diagnostics market
7.5.10 Other product market segments
7.6 UK market
7.7 Rest of Europe and rest of world markets
7.7.1 Rest of Europe
7.7.2 China
7.7.3 India
7.7.4 Rest of world
7.8 Country markets by testing discipline
CHAPTER 8 COMPANY ANALYSIS
8.1 Overview of IVD product suppliers
8.1.1 Industry leaders
8.1.2 Niche suppliers and emerging companies
8.2 Mergers and acquisitions in the IVD industry
8.3 Perspectives and strategies of key suppliers
8.3.1 Siemens Medical Solutions Diagnostics
8.3.2 GE Healthcare
8.3.3 Roche Diagnostics
CHAPTER 9 COMPANY PROFILES
9.1 Abbott Laboratories/GE Healthcare
9.2 A Menarini Diagnostics
9.3 Bayer Diabetes Care
9.4 Beckman Coulter
9.5 BD
9.6 bioMérieux
9.7 Bio-Rad Laboratories
9.8 Biosite
9.9 Cytyc
9.10 Dade Behring
9.11 Digene
9.12 Gen-Probe
9.13 Home Diagnostics
9.14 Instrumentation Laboratory
9.15 Inverness Medical Innovations
9.16 Meridian Bioscience
9.17 Olympus Clinical Instruments
9.18 Ortho Clinical Diagnostics/LifeScan
9.19 Radiometer Medical
9.20 Roche Diagnostics
9.21 Siemens Medical Solutions/Bayer Diagnostics/DPC
9.22 DiaSorin SpA
9.23 Stago
9.24 Sysmex
9.25 Tosoh
CHAPTER 10 STRATEGIES FOR SUCCESS
10.1 Consolidation and information technology
10.2 Targeting of high growth/high-value segments
10.3 Technology strategies
10.4 Marketing and distribution strategies for the clinical diagnostics market


Abstract

This report provides a comprehensive analysis of the global market for in-vitro diagnostics and projects that this market will continue to show solid growth over the next five years.

It will help you:
  • Plan your market entry strategy
  • Identify partnerships/investment opportunities
  • Analyse the market position of your competitors
  • Identify new technologies for licensing
  • Assess the competitive landscape for your products
This report will provide you information on:
  • Primary segments of the IVD market
  • Overview of the suppliers in the IVD market
  • Mergers and acquisitions in the IVD industry
  • Regulatory framework and issues for in-vitro diagnostics
  • Technology developments and trends
  • Market applications segments
  • Trends in individual country markets
  • Impact of emerging technologies



Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009